GUBOJOS VAISTINĖ - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 316,099 | 321,178 | 418,973 | 465,408 | 494,065 | 590,452 | 625,831 | 662,019 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 16,053 | 20,022 | 45,481 | 54,796 | 61,720 | 82,219 | 62,452 | 64,604 |
| Equity | 61,423 | 40,690 | 40,690 | 3,823 | 3,823 | 3,823 | 3,823 | 3,823 |
| Liabilities | 23,779 | 45,660 | 66,623 | 164,328 | 147,310 | 180,054 | 150,682 | 155,276 |
| Non-current assets | 18,239 | 13,762 | 9,483 | 3,860 | 196 | 16 | 16 | 34,345 |
| Current assets | 66,963 | 72,588 | 97,830 | 164,291 | 150,937 | 183,861 | 154,489 | 124,754 |
| Total assets | 85,202 | 86,350 | 107,313 | 168,151 | 151,133 | 183,877 | 154,505 | 159,099 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 41,705 | 52,586 | 43,924 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +26.8% | +1.6% | +30.4% | +11.1% | +6.2% | +19.5% | +6.0% | +5.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 18.8% | 23.2% | 42.4% | 32.6% | 40.8% | 44.7% | 40.4% | 40.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 26.1% | 49.2% | 111.8% | 1433.3% | 1614.4% | 2150.6% | 1633.6% | 1689.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.1% | 6.2% | 10.9% | 11.8% | 12.5% | 13.9% | 10.0% | 9.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 1.1 | 1.6 | 43.0 | 38.5 | 47.1 | 39.4 | 40.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 105,366 | 107,059 | 157,113 | 232,704 | 247,033 | 295,226 | 312,916 | 331,010 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
GUBOJOS VAISTINĖ - Social security debts
The company had no debts to Sodra
GUBOJOS VAISTINĖ - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-05 | 2025-05-05 | 239.22 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
GUBOJOS VAISTINE, UAB, company code 151455218, is a Private Limited Liability Company engaged in retail sale of pharmaceutical products. In 2025, it generated revenue of €662.0K and net profit of €64.6K, with a profit margin of 9.8%. Revenue increased by 5.8% year on year and by 12.1% over two years, rising from €590.5K in 2023 to €625.8K in 2024 and then to the latest level in 2025. Net profit moved from €82.2K in 2023 to €62.5K in 2024 and €64.6K in 2025, indicating a moderate decline from the 2023 peak but a stable result in the latest year. At the end of 2025, total assets were €159.1K, equity €3.8K and liabilities €155.3K. Long-term assets increased to €34.3K, while short-term assets were €124.8K. The company’s very small equity base means return indicators are amplified, while liabilities remain significantly above equity. Revenue per employee was €331.0K and profit per employee €32.3K, pointing to high operational productivity.